SEC Form 4 · accession 0001493152-18-005004
Co-Diagnostics, Inc. · CODX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Brent Satterfield
Officer — Chief Science Officer · Director · 10% Owner
Period of report
Apr 9, 2018
Accepted (ET)
Apr 10, 2018 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001692415
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 9, 2018 | P | 2,400 | $4,920.00 | A | 2,272,198 | D |
Table II — derivative securities
No Table II lines on this filing.